Global AI-Enabled Medical Imaging Solutions Market (2020 to 2030) - Analysis and Forecast - ResearchAndMarkets.com

 
Share

DUBLIN--(BUSINESS WIRE)--Jan 22, 2021--

The “Global AI-Enabled Medical Imaging Solutions Market: 15 Countries Analysis - Analysis and Forecast, 2020-2030" report has been added to ResearchAndMarkets.com’s offering.

The global AI-enabled medical imaging solutions market was valued at $636.1 million in 2019 and is anticipated to reach $10,145.1 million by 2030, growing at a CAGR of 26.69%, during the forecast period 2020 -2030.

The increasing complexities in clinical decision making, rising radiologist workload, and huge R&D investments are the major factors fueling market growth. In addition to these factors, there are significant challenges and restraints, which are restricting market growth. These challenges include the physicians’ reluctance toward the adoption of advanced technologies such as AI and the privacy and security concerns related to healthcare data. Hence, it is anticipated that these trends will have a significant impact on AI-enabled medical imaging solutions market in the next five years, and the market will grow multifold.

Global AI-enabled imaging modalities market is currently witnessing a significant change in the market landscape. There is rising investment in development of healthcare infrastructure, increasing evidences for efficient and promising results in treatment and diagnosis assistance. Thus, this is leading to potential growth opportunities for the AI-enabled imaging modalities market. Moreover, there is an extensive entry of emerging players developing AI-powered imaging systems, and software companies into the healthcare space. All these predominant factors have led to a significant rise in sales of AI-based imaging modality systems across the globe.

Key Questions Answered in this Report:

  • What are the various AI-enabled medical imaging solutions and systems available in the market?
  • What is the current market size and future potential of these products?
  • What are the major market drivers, challenges, and opportunities in the global AI-enabled medical imaging solutions market?
  • What are the guidelines implemented by different government bodies to regulate the approval of AI-enabled medical imaging solutions?
  • What are the key technological developments on which the current industry leaders are spending a major share of their research and development (R&D) investments?
  • Who are the leading players holding dominating shares in the global AI-enabled medical imaging solutions market, currently?
  • What are the key strategies incorporated by the players of global AI-enabled medical imaging solutions market, to sustain the competition and retain their supremacy?
  • What is the current revenue contribution of different therapeutic applications, workflow, and modality, and how would it evolve in the forecast period?
  • What is the current demand contribution of different product types and how would it evolve in the forecast period?
  • What is the current demand contribution of different deployment models and how would it evolve in the forecast period?
  • Which countries contribute to the major share of current demand and which countries hold significant scope for expansion for business activities, by players of the global AI-enabled medical imaging solutions market?

Market Dynamics

Drivers

  • Increasing Complexities of Clinical Decision -Making
  • Expanding Range of Applications
  • Shortage of Healthcare Workforce
  • Huge R&D investment

Challenges

  • Privacy and Security Concerns Related to Healthcare Data
  • Regulatory Challenges
  • Barriers to Physician’s Adoption of AI
  • Lag in Regulatory Approvals
  • Legal Implications of AI Systems
  • Rise in Medical Imaging Expenses
  • Data Security and Privacy Issues
  • Lack of Trained Staff

Opportunities

  • Rapidly Evolving Deep Learning Techniques
  • Increasing Number of Cross-Industry Partnerships

Companies Mentioned

  • Agfa-Gevaert Group
  • Aidoc
  • Arterys Inc.
  • Beijing Infervision Technology Co., Ltd.
  • Blackford Analysis Limited
  • Butterfly Network, Inc.
  • Eureka Clinical AI, formerly known as EnvoyAI
  • Fujifilm Holdings Corporation
  • General Electric Company
  • Hologic, Inc.
  • Hyperfine
  • iCAD, Inc.
  • Koninklije Philips N.V.
  • MIRADA MEDICAL LIMITED
  • Nanox
  • Nuance Communications, Inc.
  • NVIDIA Corporation
  • Siemens Healthineers AG
  • Synopsys, Inc.
  • VUNO lnc.
  • Zebra Medical Vision, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/qpv22l

View source version on businesswire.com:https://www.businesswire.com/news/home/20210122005355/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: RADIOLOGY HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2021.

PUB: 01/22/2021 11:31 AM/DISC: 01/22/2021 11:31 AM

http://www.businesswire.com/news/home/20210122005355/en